Tanvex BioPharma, Inc. (TWSE:6541) is a biopharmaceutical company focused on the biosimilar market, and we have honed our expertise in biologics development and manufacturing, culminating in the successful commercialization of our product. Our dedication to advancing healthcare has led us to expand our capabilities, now offering CDMO services. We can leverage our state-of-the-art facilities and deep knowledge in biologics development and manufacturing to bring products to market efficiently and effectively.
